Skip to content

Menu

LexBlog, Inc. logo
CommunitySub-MenuPublishersChannelsProductsSub-MenuBlog ProBlog PlusBlog PremierMicrositeSyndication PortalsAboutContactResourcesSubscribeSupport
Join
Search
Close

FDA Withdraws Draft Disease Awareness Guidance

By Meredith Manning, Heidi Gertner & Nancy Parsons on May 12, 2015
Email this postTweet this postLike this postShare this post on LinkedIn

FDA announced last week that it was withdrawing numerous draft guidance documents including its 2004 draft guidance on disease awareness activities. You can read the full Federal Register notice here.  We believe that this is largely a response to recent congressional pressure for the agency to finalize its many, long-standing draft guidances.   We spoke to an OPDP official who suggested that the decision to withdraw, rather than finalize, the existing disease awareness guidance was driven by the need to update the guidance to reflect advances in technology and incorporate new social science research.  He indicated that the withdrawal does not signify a significant departure from existing FDA policy concerning disease awareness activities.  We believe that the key legal principles underlying the draft guidance remain intact and anticipate that the agency will be hard pressed to take enforcement action against a company who has been relying in good faith on compliance with the now withdrawn guidance.  Similarly, companies who engage in disease awareness activities outside the four corners of the withdrawn guidance may be at some risk.  In other words, until we hear more from FDA – which may be some time coming – disease awareness communications should be governed by the standards articulated in the 2004 Draft Guidance.

  • Posted in:
    Administrative
  • Blog:
    Focus on Regulation
  • Organization:
    Hogan Lovells
  • Article: View Original Source

LexBlog, Inc. logo
Facebook LinkedIn Twitter RSS
Real Lawyers
99 Park Row
  • About LexBlog
  • Careers
  • Press
  • Contact LexBlog
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Terms of Service
  • RSS Terms of Service
  • Products
  • Blog Pro
  • Blog Plus
  • Blog Premier
  • Microsite
  • Syndication Portals
  • LexBlog Community
  • 1-800-913-0988
  • Submit a Request
  • Support Center
  • System Status
  • Resource Center

New to the Network

  • International Dispute Resolution
  • China Law Update Blog
  • Law of The Ledger
  • Antitrust Law Blog
  • Your ERISA Watch
Copyright © 2022, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo